Indiomin MB and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Indiomin MB and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate
Brand name: Indiomin MB, ME/NaPhos/MB/Hyo1, Uro-BLUE, Urogesic-Blue, Urolet MB, UTA, UTA
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indiomin MB-Insulin glargine, recombinant Subcutaneous
- Indiomin MB-Insulin glulisine
- Indiomin MB-Insulin Glulisine (Cartridges and Pens)
- Indiomin MB-Insulin Glulisine (Vials)
- Indiomin MB-Insulin glulisine Subcutaneous
- Indiomin MB-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Indium 111 Oxyquinoline
- Insulin glargine and lixisenatide Subcutaneous-Indium DTPA
- Insulin glargine and lixisenatide Subcutaneous-Indium In-111 Pentetreotide
- Insulin glargine and lixisenatide Subcutaneous-Indium Oxyquinoline
- Insulin glargine and lixisenatide Subcutaneous-Indocid
- Insulin glargine and lixisenatide Subcutaneous-Indocin